Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study compared the efficacy and safety of polyethylene glycol loxenatide (PEG-Loxe) and dapagliflozin in patients with mild-to-moderate diabetic kidney disease, finding both treatments effective in reducing urinary albumin-to-creatinine ratio.
This study compared the antihypertensive efficacy and safety of esaxerenone and trichlormethiazide in patients with type 2 diabetes mellitus.
The study investigated the effects of Vicadrostat and Vicadrostat plus Empagliflozin on urinary extracellular vesicle microRNAs in chronic kidney disease. Significant decreases in urinary albumin-to-creatinine ratio were observed with both treatments.
This study evaluated the effects of Tirzepatide on glycemic control and body weight in Bangladeshi patients with Type 2 diabetes during Ramadan fasting, demonstrating significant improvements.
This study investigated the effects of exenatide treatment on serum irisin levels in patients with type 2 diabetes mellitus (T2DM), finding a significant decline in irisin levels.
This study investigated the effects of different exercise modalities on serum albumin levels in women with type 2 diabetes, finding significant reductions in body weight and fasting plasma glucose levels.
This pilot trial investigated the safety and metabolic effects of fecal microbiota transplantation (FMT) capsules in adults with obesity and insulin resistance, finding no significant improvements compared to placebo.
This study evaluated the effects of a lifestyle intervention on obese women with obstructive sleep apnea, finding significant weight reduction and improvements in metabolic parameters.
Short-term hands-on nutrition education via WeChat improved HbA1c levels in Type 2 diabetes patients.
This study evaluated the effectiveness of the Lifestyle Africa diabetes prevention program in low-resource settings. It found no significant difference in weight loss compared to usual care, but a notable reduction in HbA1c levels.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
